Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,01 USD | -0,99% | -4,07% | -83,86% |
14/05 | RAPT THERAPEUTICS, INC. : Wolfe Research verlaagt advies naar Neutraal | ZM |
10/05 | RAPT THERAPEUTICS, INC. : Guggenheim verlaagt advies naar Neutraal | ZM |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 140 mln. 129 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -109 mln. -100 mln. | Nettowinst (verlies) 2025 * | -132 mln. -122 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 152 mln. 140 mln. | Nettoliquiditeiten 2025 * | 216 mln. 199 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-1,44
x | K/w-verhouding 2025 * |
-1,46
x | Werknemers | 126 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94,64% |
Recentste transcriptie over RAPT Therapeutics, Inc.
1 dag | -0,99% | ||
1 week | -4,07% | ||
1 maand | -50,65% | ||
3 maanden | -55,35% | ||
6 maanden | -75,20% | ||
Lopend jaar | -83,86% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Brian Wong
CEO | Chief Executive Officer | 52 | 01-08-15 |
Rodney Young
DFI | Director of Finance/CFO | 61 | 02-12-19 |
Jim Farmer
CTO | Chief Tech/Sci/R&D Officer | - | 04-05-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 04-12-19 |
William Rieflin
CHM | Chairman | 64 | 01-05-15 |
Wendye Robbins
BRD | Director/Board Member | 63 | 22-10-19 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.05% | 0 M€ | 0,00% | - | |
0.05% | 0 M€ | 0,00% | - | |
0.02% | 234 M€ | +8,48% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
31-05-24 | 4,01 | -0,99% | 1 038 471 |
30-05-24 | 4,05 | +2,53% | 583 549 |
29-05-24 | 3,95 | -3,07% | 595 766 |
28-05-24 | 4,075 | -2,51% | 383 018 |
uitgestelde koers Nasdaq, 31 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-83,86% | 140 mln. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. | |
+77,64% | 8,87 mld. |